Dr. Daniel Peter Petrylak M.D.
Oncologist | Medical Oncology
161 Fort Washington Ave New York NY, 10032About
Dr. Daniel Petrylak is an oncologist practicing in New York, NY. Dr. Petrylak specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Petrylak manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer.
- Chemotherapy for advanced hormone refractory prostate cancer.
- Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.
- Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A Southwest Oncology Group Study.
- Docetaxel (Taxotere) in hormone-refractory prostate cancer.
- Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.
- Transitional cell carcinoma of the bladder: new approaches to the treatment of advanced disease.
- Combination therapy in hormone-refractory prostate cancer.
- Salvage therapy for platinum-refractory urothelial cancer: designing new clinical trials.
- Editorial: the coming revolution in the treatment of prostate cancer patients.
- Chemotherapy for androgen-independent prostate cancer.
- The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
- Refractory disease, new horizons and patient-physician relationships.
- A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.
- Early chemohormonal therapy in prostate cancer: preliminary data and randomized trials.
Clinical Trials
Dr. Daniel Peter Petrylak M.D.'s Practice location
Dr. Daniel Peter Petrylak M.D.'s reviews
Write ReviewRecommended Articles
- Ovarian Cancer: What Every Young Woman Must Know
Any type of cancer diagnosis can be startling and overwhelming; however, an ovarian cancer diagnosis can be even more upsetting to women and their loved ones because of its high mortality rate. Ovarian cancer, often referred to as the “silent killer”, is known as the 5th most common and...
- What Is Liver Cancer: Get the Facts
Liver cancer happens when the liver's normal cells change in behavior and appearance. As a result, the abnormal liver cells divide and grow uncontrollably. Liver cancer is also referred to as "hepatic cancer", which can either be primary or secondary. The liver is a large organ that is located...
- What Women with Breast Cancer Can Do About Depression
Breast cancer impacts millions of women each year. Beyond the physical impact of the disease, breast cancer can present a myriad of other hurdles for patients and women who are in remission.In the United States, women have a 1 in 8 chance of developing breast cancer at some point in her...
- Alternative Treatments for Liver Cancer
Alternative treatments for liver cancer refer to alternative medical procedures rather than the conventional and allopathic medications used to treat liver cancer. They include herbs, traditional Chinese medicine and homeopathy among others. The alternative treatments require a certification and...
- Breast Cancer Survivor Raises Money to Pay Bills for Others Who Need Care
Medical care in the United States is among one of the most expensive in the world. Even when receiving preventative care, bills can quickly rack up and become overwhelming for the average family. Imagine what happens when a terrible disease strikes.The cost of treatment deadly illnesses such as...
- Revealing a Terminal Ovarian Cancer: A Personal Story
A terminal cancer diagnosis is an extremely difficult thing to process, and the hardship is only amplified when sharing the news with someone who loves you. There is a stress surrounding how to break the news, and a worry for how they will cope with it.This is how Linda Tierney decided to tell her...
Nearby Providers
- Dr. Donna McNamara MD92 2nd Street Hackensack NJ 07601
- Howard W. Bruckner2330 Eastchester Rd Bronx New York 10469
- Dr. William H. Nealon M.D.450 Lakeville Road New Hyde Park NY 11042
- Dr. Trevor Joseph Layne MD354 MAIN ST WEST ORANGE NJ 07052
- Rachel Beth Wellner1185 Park Ave New York NY 10128
- Orestes Sanchez703 Main St Paterson New Jersey 07503